ヒトミルクオリゴ糖の世界市場分析:用途別(乳児用調合乳、機能性食品・飲料、食品サプリメント)、セグメント予測

【英語タイトル】Human Milk Oligosaccharides Market Analysis By Application (Infant Formula, Functional Food & Beverages, Food Supplements) And Segment Forecasts To 2022

Grand View Researchが出版した調査資料(GVIEW707410)・商品コード:GVIEW707410
・発行会社(調査会社):Grand View Research
・発行日:2016年6月21日
・ページ数:89
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:Personal Care & Cosmetics
◆販売価格オプション(消費税別)
Single UserUSD4,700 ⇒換算¥517,000見積依頼/購入/質問フォーム
Multi UserUSD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Global/corporate LicenseUSD10,500 ⇒換算¥1,155,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、ヒトミルクオリゴ糖の世界市場について調査・分析し、ヒトミルクオリゴ糖の世界市場動向、ヒトミルクオリゴ糖の世界市場規模、市場予測、セグメント別ヒトミルクオリゴ糖市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

Global human milk oligosaccharides market is expected to reach USD 134.7 million by 2022, according to a new report by Grand View Research, Inc. The human milk oligosaccharides industry is expected to witness significant demand owing to increasing need from infant formula and functional food & beverage applications.
Numerous players have been investing for development of new technologies for commercial scale product manufacturing, thus augmenting growth. For instance, Inbiose N.V. uses fermentation process for commercial scale production of human milk oligosaccharides.

Rising concern regarding gut health coupled with increasing dairy industry is expected to augment product demand in dairy and pharmaceutical applications. Changing consumer lifestyles and shift towards nutritious food is expected to boost product need over the forecast period. In addition, issues related to infant malnutrition and mortality throughout the world is expected to augment product over the next seven years.

Further key findings from the report suggest:

Infant Formula was the largest application, accounting for over 70% of global volume in 2014. High infant mortality rate coupled with increased need of the product for infants deprived of mother’s milk is expected to propel demand.

Functional food & beverages are expected to witness rise on account of growing awareness towards gut health. In addition, rapidly growing need for better healthcare services and nutritional food products in Asia Pacific and Latin America is expected to fuel growth over the next seven years. The segment is expected to grow at a CAGR of 17.9% from 2015 to 2022.

Europe was the dominant region in terms of volume, accounting for over 35.0% of the total share in 2014 primarily due to growing demand for prebiotic products. Europe human milk oligosaccharides demand is expected to grow at a significant rate owing to regulations promoting use of 2’FL and LNnT in infant formulas.

The global market is consolidated with limited players dominating the industry. Key companies present include Inbiose, Elicityl SA, Jennewein Biotechnologie, Glycom, Medolac Laboratories, ZuChem, and Glycosyn. These companies are extensively involved in R&D activities for the product. Moreover, some of the players including Glycom A/S are integrated across the value chain, where they produce the raw materials used in manufacturing of HMOs.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. HMO Market – Industry Summary and Key Buying Criteria, 2012 – 2022
Chapter 3. HMO Industry Outlook
3.1. HMO market segmentation
3.2. HMO market size and growth prospects, 2012 – 2022
3.3. HMO market – Value chain analysis
3.3.1. Vendor landscape
3.4. Raw material outlook, 2012 – 2022
3.5. Technology overview
3.6. Regulatory framework
3.7. HMO market dynamics
3.7.1. Market driver analysis
3.7.2. Market restraint analysis
3.8. Key market opportunities – Prioritized
3.9. Industry analysis – Porter’s
3.10. HMO market PESTEL analysis, 2014
3.11. HMO market competitive landscape, 2014
3.12. HMO market pricing trends
Chapter 4 HMO Product Outlook
4.1. 2’-Fucosyllactose (2’FL)
4.1.1 : Specifications
4.1.2 : Key Suppliers
4.1.3 : Applications
4.1.4 : Patents
4.1.5 : Production Routes
4.1.6 : Manufacturers
4.2. 3’-Fucosyllactose (3’FL)
4.2.1 : Specifications
4.2.2 : Key Suppliers
4.2.3 : Applications
4.2.4 : Patents
4.2.5 :Production Routes
4.2.6 : Manufacturers
4.3. 3’-Sialyllactose (3’SL)
4.3.1 : Specifications
4.3.2 : Key Suppliers
4.3.3 :Applications
4.3.4 : Patents
4.3.5 : Production Routes
4.3.6 : Manufacturers
4.4. 6’-Sialyllactose (6’SL)
4.4.1 : Specifications
4.4.2 : Key Suppliers
4.4.3 : Applications
4.4.4 : Patents
4.4.5 : Production Routes
4.4.6 : Manufacturers
4.5 Lacto-N-tetraose (LNT)
4.5.1 : Specifications
4.5.2 : Key Suppliers
4.5.3 : Patents
4.5.4 : Applications
4.5.5 : Production Routes
4.5.6 : Manufacturers
4.6. Lacto-N-neotetraose (LNnT)
4.6.1 : Specifications
4.6.2 : Key Suppliers
4.6.3 : Patents
4.6.4 : Applications
4.6.5 : Production Routes
4.6.6 : Manufacturers
Chapter 5. HMO Application Outlook
5.1. Global HMO market share by application, 2014 & 2022
5.2. Infant Formula
5.2.1. Market estimates and forecast, 2012 – 2022
5.2.2. Market estimates and forecast, by region, 2012 – 2022
5.3. Functional Food & Beverages
5.3.1. Market estimates and forecast, 2012 – 2022
5.3.2. Market estimates and forecast, by region, 2012 – 2022
5.4. Food Supplements
5.4.1. Market estimates and forecast, 2012 – 2022
5.4.2. Market estimates and forecast, by region, 2012 – 2022
5.5. Others
5.5.1. Market estimates and forecast, 2012 – 2022
5.5.2. Market estimates and forecast, by region, 2012 – 2022
Chapter 6. HMO Regional Outlook
6.1. Global HMO market share by region, 2014 & 2022
6.2. North America
6.2.1. North America market estimates and forecast, 2012 – 2022
6.2.2. North America market estimates and forecast by application, 2012 – 2022
6.2.3. U.S.
6.2.3.1. U.S. market estimates and forecast by application, 2012 – 2022
6.3. Europe
6.3.1. Europe market estimates and forecast, 2012 – 2022
6.3.2. Europe market estimates and forecast by application, 2012 – 2022
6.3.3. UK
6.3.3.1. UK market estimates and forecast by application, 2012 – 2022
6.3.4. Germany
6.3.4.1. Germany market estimates and forecast by application, 2012 – 2022
6.4. Asia Pacific
6.4.1. Asia Pacific market estimates and forecast, 2012 – 2022
6.4.2. Asia Pacific market estimates and forecast by application, 2012 – 2022
6.4.3. China
6.4.3.1. China market estimates and forecast by application, 2012 – 2022
6.4.4. Japan
6.4.4.1. Japan market estimates and forecast by application, 2012 – 2022
6.5. Latin America
6.5.1. Latin America market estimates and forecast, 2012 – 2022
6.5.2. Latin America market estimates and forecast by application, 2012 – 2022
6.5.3. Brazil
6.5.3.1. Brazil market estimates and forecast by application, 2012 – 2022
6.6. MEA
6.6.1. MEA market estimates and forecast, 2012 – 2022
6.6.2. MEA market estimates and forecast by application, 2012 – 2022
Chapter 7. Competitive Landscape
7.1. Inbiose
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2. Elicityl SA
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3. Jennewein Biotechnologie
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4. Glycom
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5. Medolac Laboratories
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6. ZuChem
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7. Glycosyn
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives

List of Figures

1. HMO market segmentation
2. Global HMO market volume and revenue, 2012 - 2022 (Grams) (USD 000)
3. HMO Market - Value chain analysis
4. HMO: Raw material outlook
5. HMO market dynamics
6. Global dairy product market, 2008 & 2012 (Million Tons)
7. Global Dietary Supplements Market, 2012-2020, (USD Million)
8. HMO- Key opportunities prioritized
9. HMO Porter’s analysis
10. HMO market PESTEL analysis
11. HMO market pricing trends, 2012 - 2022 (USD/100mg)
12. Global HMO market volume share by application, 2014 & 2022
13. Global HMO market volume share by region, 2014 & 2022



★調査レポート[ヒトミルクオリゴ糖の世界市場分析:用途別(乳児用調合乳、機能性食品・飲料、食品サプリメント)、セグメント予測] (コード:GVIEW707410)販売に関する免責事項を必ずご確認ください。
★調査レポート[ヒトミルクオリゴ糖の世界市場分析:用途別(乳児用調合乳、機能性食品・飲料、食品サプリメント)、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆